Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-20

FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for Lanthanum carbonate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

SUPPL AP for LANTHANUM CARBONATE (LANTHANUM CARBONATE)